Randomized feasibility trial of directly observed versus unobserved hepatitis C treatment with ledipasvir-sofosbuvir among people who inject drugs
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Randomized feasibility trial of directly observed versus unobserved hepatitis C treatment with ledipasvir-sofosbuvir among people who inject drugs
Authors
Keywords
Hepatitis C virus, Drug therapy, Drug screening, Adverse events, RNA sequencing, Drug metabolism, HIV prevention, Urology
Journal
PLoS One
Volume 14, Issue 6, Pages e0217471
Publisher
Public Library of Science (PLoS)
Online
2019-06-04
DOI
10.1371/journal.pone.0217471
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Impact of current and scaled-up levels of hepatitis C prevention and treatment interventions for people who inject drugs in three UK settings-what is required to achieve the WHO's HCV elimination targets?
- (2018) Zoe Ward et al. ADDICTION
- Increases in Acute Hepatitis C Virus Infection Related to a Growing Opioid Epidemic and Associated Injection Drug Use, United States, 2004 to 2014
- (2018) Jon E. Zibbell et al. AMERICAN JOURNAL OF PUBLIC HEALTH
- How to eliminate HCV infection by antiviral treatment
- (2017) Natasha K. Martin et al. JOURNAL OF HEPATOLOGY
- Recovery of Infectious Hepatitis C Virus From Injection Paraphernalia: Implications for Prevention Programs Serving People Who Inject Drugs
- (2017) Robert Heimer et al. JOURNAL OF INFECTIOUS DISEASES
- Direct-acting antiviral agents for HCV infection affecting people who inject drugs
- (2017) Jason Grebely et al. Nature Reviews Gastroenterology & Hepatology
- Incidence of Hepatitis C Virus Infection in the Human Immunodeficiency Virus Outpatient Study Cohort, 2000–2013
- (2017) Taraz Samandari et al. Open Forum Infectious Diseases
- Elbasvir–Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy
- (2016) Gregory J. Dore et al. ANNALS OF INTERNAL MEDICINE
- Efficacy and Safety of Ledipasvir/Sofosbuvir With and Without Ribavirin in Patients With Chronic HCV Genotype 1 Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ION Trials
- (2016) Jason Grebely et al. CLINICAL INFECTIOUS DISEASES
- Rising Mortality Associated With Hepatitis C Virus in the United States, 2003–2013
- (2016) Kathleen N. Ly et al. CLINICAL INFECTIOUS DISEASES
- Treatment adherence and virological response rates in hepatitis C virus infected persons treated with sofosbuvir-based regimens: results from ERCHIVES
- (2016) Adeel A. Butt et al. LIVER INTERNATIONAL
- Estimating the Number of Persons Who Inject Drugs in the United States by Meta-Analysis to Calculate National Rates of HIV and Hepatitis C Virus Infections
- (2014) Amy Lansky et al. PLoS One
- Intimate Injection Partnerships Are at Elevated Risk of High-Risk Injecting: A Multi-Level Longitudinal Study of HCV-Serodiscordant Injection Partnerships in San Francisco, CA
- (2014) Meghan D. Morris et al. PLoS One
- Hepatitis C Virus Reinfection Following Treatment Among People Who Use Drugs
- (2013) Bart P. Grady et al. CLINICAL INFECTIOUS DISEASES
- Combination Interventions to Prevent HCV Transmission Among People Who Inject Drugs: Modeling the Impact of Antiviral Treatment, Needle and Syringe Programs, and Opiate Substitution Therapy
- (2013) Natasha K. Martin et al. CLINICAL INFECTIOUS DISEASES
- Injection Drug Use and Hepatitis C Virus Infection in Young Adult Injectors: Using Evidence to Inform Comprehensive Prevention
- (2013) Kimberly Page et al. CLINICAL INFECTIOUS DISEASES
- Cost-Effectiveness of HIV Treatment as Prevention in Serodiscordant Couples
- (2013) Rochelle P. Walensky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Injecting Risk Behavior among Traveling Young Injection Drug Users: Travel Partner and City Characteristics
- (2012) Martha E. Montgomery et al. JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE
- Cost-effectiveness of hepatitis C virus antiviral treatment for injection drug user populations
- (2011) Natasha K. Martin et al. HEPATOLOGY
- Prevention of HIV-1 Infection with Early Antiretroviral Therapy
- (2011) Myron S. Cohen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Survival of Hepatitis C Virus in Syringes: Implication for Transmission among Injection Drug Users
- (2010) Elijah Paintsil et al. JOURNAL OF INFECTIOUS DISEASES
- Acute Hepatitis C Virus Infection in Young Adult Injection Drug Users: A Prospective Study of Incident Infection, Resolution, and Reinfection
- (2009) Kimberly Page et al. JOURNAL OF INFECTIOUS DISEASES
- The influence of needle exchange programs on injection risk behaviors and infection with hepatitis C virus among young injection drug users in select cities in the United States, 1994–2004
- (2009) Deborah Holtzman et al. PREVENTIVE MEDICINE
- Hepatitis C Virus Acquisition among Injecting Drug Users: A Cohort Analysis of a National Repeated Cross-sectional Survey of Needle and Syringe Program Attendees in Australia, 1995–2004
- (2008) Kathleen Falster et al. JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started